Serum metabolomic biomarkers of dementia.

At the preclinical phase, only a weak trend towards a group difference in performance was seen, whereas a marked group difference in memory performance was apparent at the time of diagnosis.

also in 834 other papers

A difference in performance began to emerge 5 years prior to the diagnosis (preclinical phase), and a marked difference was apparent at the time of the diagnosis.

also in 455 other papers